Results 81 to 90 of about 28,764 (283)

Exendin-4 Protects Against Sulfonylurea-Induced β-Cell Apoptosis

open access: yes, 2012
Sulfonylurea is one of the commonly used anti-diabetic drugs that stimulate insulin secretion from β-cells. Despite their glucose lowering effects in type 2 diabetes mellitus, long-term treatment brought on secondary failure characterized by β-cell ...
Chan-Il Moon   +8 more
core   +1 more source

Ethnicity is associated with variation in diabetes emergency outcomes: Findings from the DEKODE audit and feedback programme

open access: yesDiabetic Medicine, EarlyView.
Abstract Background Although ethnic disparities in diabetes prevalence and chronic complications are well recognised, their association with acute metabolic emergencies and outcomes is not well established. In this study, we investigated the association between ethnicity and clinical outcomes.
Aspasia Manta   +40 more
wiley   +1 more source

From ions to insulin

open access: yeseLife, 2017
Electron cryo-microscopy has revealed the three-dimensional structure of a potassium channel that has a central role in regulating the release of insulin from the pancreas.
Voula Kanelis
doaj   +1 more source

Influence of auxin and sulfonylurea herbicides on seeded native communities

open access: yes, 2004
Sulfonylurea herbicides were used extensively for weed control on Conservation Reserve Program (CRP) seedings, constituting over 98% of the residual herbicides applied from 1986-1990 in southeastern Colorado.
Lair, Kenneth, Redente, Edward F.
core   +1 more source

Kidney Outcomes With GLP‐1 Receptor Agonists and Tirzepatide Versus Finerenone in Type 2 Diabetes and Chronic Kidney Disease: A Real‐World Cohort Study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim To compare kidney outcomes after GLP‐1 receptor agonists (RA) or tirzepatide (GLP‐1/GIP RAs) versus finerenone initiation in adults with Type 2 diabetes (T2D) and moderate chronic kidney disease (CKD). Methods In a retrospective TriNetX global network study (July 2021–November 2025), adults with T2D and CKD stages 3–4 initiating GLP‐1/GIP ...
Dvora R. Sehtman‐Shachar   +5 more
wiley   +1 more source

Cardiac Effects of Sulfonylurea-Related Hypoglycemia

open access: yes, 2017
OBJECTIVE To determine the effect of sulfonylurea-related hypoglycemia on cardiac repolarization and ectopy in the setting of well-controlled type 2 diabetes. RESEARCH
Lynda Molyneaux   +6 more
core   +1 more source

Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis [PDF]

open access: yes, 2013
AIMS/HYPOTHESIS: Sulfonylureas are widely prescribed glucose-lowering medications for diabetes, but the extent to which they improve glycaemia is poorly documented.
R. J. Stevens   +9 more
core   +1 more source

Genetics‐Informed Pharmacological Intervention in Gestational Diabetes Mellitus: Current Therapeutic Alignment, Emerging Targets and a Translational Roadmap

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Gestational diabetes mellitus (GDM) complicates roughly one in seven pregnancies and predicts later maternal type 2 diabetes mellitus (T2DM). Yet its pharmacological management still rests on a handful of agents (insulin, metformin and glibenclamide), none of them selected on the basis of the disease's molecular genetics.
Wael Osman
wiley   +1 more source

Bioequivalence Study of a New Generic Fixed-Dose Combination of Sitagliptin (100 mg) and Glimepiride (2 mg) in Healthy Adult Volunteers under Fasting Condition

open access: yesChronicle of Diabetes Research and Practice
Introduction: The present study evaluated the bioequivalence of a fixed-dose combination (FDC) of sitagliptin and glimepiride with the originator reference product.
Prashant Kumthekar   +4 more
doaj   +1 more source

Ligand binding and conformational changes of SUR1 subunit in pancreatic ATP-sensitive potassium channels

open access: yesProtein & Cell, 2018
ATP-sensitive potassium channels (KATP) are energy sensors on the plasma membrane. By sensing the intracellular ADP/ATP ratio of β-cells, pancreatic KATP channels control insulin release and regulate metabolism at the whole body level.
Jing-Xiang Wu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy